Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary breast lymphoma.

D Gholam1, F Bibeau, A El Weshi

  • 1Department of Medicine, Institut Gustave Roussy, Villejuif, France.

Leukemia & Lymphoma
|August 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study.

Leukemia & lymphoma·2024
Same author

Infections occurring following IL6 blockade for the management of cytokine release syndrome in onco-hematology patients.

Cancer chemotherapy and pharmacology·2023
Same author

Incidence, characteristics, management and outcome of patients with follicular lymphoma with tumor epidural compression, a study on 22 cases.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026
Same journal

Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLL.

Leukemia & lymphoma·2026
Same journal

Association between interleukin-10 (IL-10) genetic polymorphisms and non-hodgkin lymphoma: a systematic review and meta-analysis.

Leukemia & lymphoma·2026
Same journal

An indirect comparison of pirtobrutinib with second-generation covalent Bruton tyrosine kinase inhibitors in BTKi naive, and relapsed-refractory chronic lymphocytic leukemia: results of a network meta-analysis.

Leukemia & lymphoma·2026
Same journal

Efficacy of allogeneic haematopoietic stem cell transplantation in acute myeloid leukemia with myelodysplasia-related genetics.

Leukemia & lymphoma·2026
Same journal

Shared decision-making, treatment priorities and communication gaps in chronic lymphocytic leukemia: an Israeli national survey.

Leukemia & lymphoma·2026
See all related articles

Primary breast lymphoma (PBL) treatment with chemotherapy shows high remission rates but a significant risk of central nervous system (CNS) relapse. CNS prophylaxis is recommended for localized PBL patients receiving systemic chemotherapy.

Area of Science:

  • Oncology
  • Hematology
  • Clinical Research

Background:

  • Primary breast lymphoma (PBL) is a rare extranodal lymphoma with limited treatment data.
  • Extranodal lymphomas require specific treatment considerations and outcome analysis.

Purpose of the Study:

  • To evaluate the treatment outcomes and relapse patterns of primary breast lymphoma (PBL).
  • To determine the efficacy of CHOP chemotherapy in PBL and assess the incidence of central nervous system (CNS) relapse.

Main Methods:

  • Retrospective analysis of 20 consecutive primary breast lymphoma (PBL) cases treated with CHOP or similar chemotherapy regimens.
  • Histological review of biopsy specimens and detailed follow-up for treatment response, relapse, and survival.

Main Results:

Related Experiment Videos

  • 16 of 20 patients achieved complete remission (CR) with CHOP chemotherapy.
  • A high incidence of central nervous system (CNS) relapse was observed (2/20 initial cases, plus 2 PR patients progressing to CNS).
  • 15% of patients experienced contralateral breast relapse; 12 patients were alive at follow-up.

Conclusions:

  • CHOP chemotherapy is effective in achieving remission for primary breast lymphoma (PBL).
  • There is a notable risk of central nervous system (CNS) relapse in localized PBL.
  • Prophylactic CNS treatment should be considered alongside systemic chemotherapy for localized PBL.